tyrosyl-arginyl-phenylalanyl-lysinamide and naltrindole

tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with naltrindole in 1 studies

Compound Research Comparison

Studies (tyrosyl-arginyl-phenylalanyl-lysinamide)	Trials (tyrosyl-arginyl-phenylalanyl-lysinamide)	Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide)	Studies (naltrindole)	Trials (naltrindole)	Recent Studies (post-2010) (naltrindole)
74	0	17	801	0	139

Protein Interaction Comparison

Protein	Taxonomy	tyrosyl-arginyl-phenylalanyl-lysinamide (IC50)	naltrindole (IC50)
Delta-type opioid receptor	Mus musculus (house mouse)		0.0007
Delta-type opioid receptor	Homo sapiens (human)		0.0006

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Neilan, CL; Nguyen, TM; Pasternak, GW; Schiller, PW	1

Other Studies

1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and naltrindole

Article	Year
Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide. European journal of pharmacology, 2001, May-04, Volume: 419, Issue:1 Topics: Analgesics; Animals; Drug Tolerance; Humans; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Oligodeoxyribonucleotides, Antisense; Oligopeptides; Opioid Peptides; Pain Measurement; Receptors, Opioid, mu; Time Factors	2001

Article

Year

Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide.

European journal of pharmacology, 2001, May-04, Volume: 419, Issue:1

Topics: Analgesics; Animals; Drug Tolerance; Humans; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Oligodeoxyribonucleotides, Antisense; Oligopeptides; Opioid Peptides; Pain Measurement; Receptors, Opioid, mu; Time Factors

2001